胃食道逆流症(GERD)治療薬の世界市場分析:薬の種類別(制酸薬、プロトンポンプ阻害薬、H2受容体遮断薬、プロキネティック薬)、地域別、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Gastroesophageal Reflux Disease (GERD) Therapeutics Market Analysis By Drug Type (Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro-Kinetic Agents), By Region, And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic scope & assumptions
1.4 Region-wise Market Calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 GERD Therapeutics Market Variables, Trends & Scope
3.1 Market Segmentation&Scope
3.1.1 Market drivers analysis
3.1.2 Market Restraints Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 GERD therapeutics- SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 GERD Therapeutics Market: Drug Type Estimates & Trend Analysis
4.1 GERD Therapeutics Market: Drug type movement analysis
4.2 Antacids
4.2.1 Antacids market, 2014 – 2025 (USDMillion)
4.3 H2 Receptor Blockers
4.3.1 H2 receptor blockers market, 2014 – 2025 (USDMillion)
4.4 Proton Pump Inhibitors
4.4.1 Proton pump inhibitors market, 2014 – 2025 (USDMillion)
4.5 Pro-kinetic Agents
4.5.1 Pro-kinetic agents market, 2014 – 2025 (USDMillion)
Chapter 5 GERD Therapeutics Market: Regional Estimates & Trend Analysis
5.1 GERD Therapeutics Market Share, by Region, 2015 & 2025
5.2 North America
5.2.1 North America GERD therapeutics market, 2014 – 2025 (USDMillion)
5.2.2 U.S
5.2.2.1 U.S GERD therapeutics market, 2014 – 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada GERD therapeutics market, 2014 – 2025 (USDMillion)
5.3 Europe
5.3.1 Europe GERD therapeutics market, 2014 – 2025 (USDMillion)
5.3.2 UK
5.3.2.1 UK GERD therapeutics market, 2014 – 2025 (USDMillion)
5.3.3 Germany
5.3.3.1 Germany GERD therapeutics market, 2014 – 2025 (USDMillion)
5.4 Asia Pacific
5.4.1 Asia Pacific GERD therapeutics market, 2014 – 2025 (USDMillion)
5.4.2 Japan
5.4.2.1 Japan GERD therapeutics market, 2014 – 2025 (USDMillion)
5.4.3 China
5.4.3.1 China GERD therapeutics market, 2014 – 2025 (USDMillion)
5.5 Latin America
5.5.1 Latin America GERD therapeutics market, 2014 – 2025 (USDMillion)
5.5.2 Brazil
5.5.2.1 Brazil GERD therapeutics market, 2014 – 2025 (USDMillion)
5.6 MEA
5.6.1 MEA GERD therapeutics market, 2014 – 2025 (USDMillion)
5.6.2 South Africa
5.6.2.1 South Africa GERD therapeutics market, 2014 – 2025 (USDMillion)
Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Takeda Pharmaceutical Co., Ltd.
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 AstraZeneca PLC
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Eisai Co., Ltd.
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 GlaxoSmithKline PLC
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 Johnson & Johnson Services, Inc.
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 Daewoong Pharmaceutical Co., Ltd
6.3.6.1 Company overview
6.3.6.2 Financial overview
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 Ironwood Pharmaceuticals, Inc.
6.3.7.1 Company overview
6.3.7.2 Financial overview
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 RaQualia Pharma, Inc.
6.3.8.1 Company overview
6.3.8.2 Financial overview
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
6.3.9 SFJ Pharmaceuticals Group
6.3.9.1 Company overview
6.3.9.2 Financial overview
6.3.9.3 Product benchmarking
6.3.9.4 Strategic initiatives
6.3.10 SRS Pharmaceuticals Pvt. Ltd
6.3.10.1 Company overview
6.3.10.2 Financial overview
6.3.10.3 Product benchmarking
6.3.10.4 Strategic initiatives
6.3.11 Reckitt Benckiser Group PLC
6.3.11.1 Company overview
6.3.11.2 Financial overview
6.3.11.3 Product benchmarking
6.3.11.4 Strategic initiatives
6.3.12 Novartis AG
6.3.12.1 Company overview
6.3.12.2 Financial overview
6.3.12.3 Product benchmarking
6.3.12.4 Strategic initiatives
6.3.13 Pfizer, Inc.
6.3.13.1 Company overview
6.3.13.2 Financial overview
6.3.13.3 Product benchmarking
6.3.13.4 Strategic initiatives
6.3.14 Abbott
6.3.14.1 Company overview
6.3.14.2 Financial overview
6.3.14.3 Product benchmarking
6.3.14.4 Strategic initiatives


【レポート販売概要】

■ タイトル:胃食道逆流症(GERD)治療薬の世界市場分析:薬の種類別(制酸薬、プロトンポンプ阻害薬、H2受容体遮断薬、プロキネティック薬)、地域別、セグメント予測、2014-2025
■ 英文:Gastroesophageal Reflux Disease (GERD) Therapeutics Market Analysis By Drug Type (Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro-Kinetic Agents), By Region, And Segment Forecasts, 2014-2025
■ 発行日:2017年2月20日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707353
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。